U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Name Type Language
VONLEROLIZUMAB
INN   USAN  
INN   USAN  
Official Name English
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS TNFRSF4(TUMOR NECROSIS FACTOR RECEPTOR (TNFR) SUPERFAMILY MEMBER 4, ACT35, OX40, CD134)), HUMANIZED MONOCLONAL ANTIBODY
Common Name English
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HUMAN TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 4 (ACT35 ANTIGEN, OX40L RECEPTOR, CD134 ANTIGEN))HUMANIZED MOUSE MONOCLONAL ANTIBODY: .GAMMA.1 HEAVY CHAIN (1-447) (HUMANIZED MOUSE VH (HOMO SAPIENS IGHV1-46*01 (81%)
Systematic Name English
RG 7888 [WHO-DD]
Common Name English
R0-7021608
Code English
Vonlerolizumab [WHO-DD]
Common Name English
RG7888
Code English
POGALIZUMAB
WHO-DD  
INN  
Official Name English
vonlerolizumab [INN]
Common Name English
MOXR-0916
Code English
R07021608
Code English
RG-7888
Code English
MOXR0916
Code English
VONLEROLIZUMAB [USAN]
Common Name English
Code System Code Type Description
CAS
1638935-72-4
Created by admin on Sat Dec 16 11:24:56 GMT 2023 , Edited by admin on Sat Dec 16 11:24:56 GMT 2023
PRIMARY
NCI_THESAURUS
C121376
Created by admin on Sat Dec 16 11:24:56 GMT 2023 , Edited by admin on Sat Dec 16 11:24:56 GMT 2023
PRIMARY
INN
10272
Created by admin on Sat Dec 16 11:24:56 GMT 2023 , Edited by admin on Sat Dec 16 11:24:56 GMT 2023
PRIMARY
FDA UNII
C78148TF1D
Created by admin on Sat Dec 16 11:24:56 GMT 2023 , Edited by admin on Sat Dec 16 11:24:56 GMT 2023
PRIMARY
USAN
DE-168
Created by admin on Sat Dec 16 11:24:56 GMT 2023 , Edited by admin on Sat Dec 16 11:24:56 GMT 2023
PRIMARY
ACTIVE MOIETY
VONLEROLIZUMAB
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966